Partnerships & Innovation Drive Concepts in Biotherapeutics
— Never miss a story with notifications — Gain full access to our premium content — Browse free from any location or device. Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results! – Access the Media Pack Now – Leave Message for Us to Get Back […]
Buyout of SpringWorks Brings Back Merck KGaA in the M&A Game
Merck KGaA’s long-standing courtship of SpringWorks Therapeutics has finally come to a realization as the German drugmaker has purchased the Connecticut biopharma for an equity valuation of $3.9 billion, the company recently said. The deal, which amounts to $47 per share, goes on to enhance Merck KGaA’s presence across the US and also throttles its […]
Ethical AI Investment: The Key to Sustainable Healthcare Innovation in Europe
In this exclusive interview, World Pharma Today sits down with Laurent Van Lerberghe and David Buller, the Managing Partners of KELES, deeply engaged in ethical AI investments, particularly within the healthcare and pharmaceutical sectors. The conversation explores their insights into the role of ethical AI in business, challenges in transparency and accountability, compliance with evolving […]
Drug Formulation Market Growth Forecast 2025-2035
The Future of Medicine: A Comprehensive Insight into the Drug Formulation Market (2025-2035) New technologies, changing patient needs, and health problems around the world are all causing the pharmaceutical business to go through a huge change. The Drug Formulation Market is expected to grow quickly, rising from USD 1.7 trillion in 2025 to USD 2.8 […]
Thermo Fisher Scientific Leverages Integrated Solutions to Accelerate the Development of Biologic Therapeutics
Thermo Fisher Scientific, a prominent figure in the scientific community, is utilising an advanced platform technology along with a new CHO K-1 cell line that can shorten the timeline for Investigational New Drug (IND) filing from 13 to nine months. This innovation aids biotech and pharmaceutical companies in navigating the logistical challenges associated with pre-clinical […]
Small Molecule API Market Growth Analysis and Future Trends
Small Molecule API Market Size, Share, and Growth Analysis The world’s healthcare sector is experiencing an increase in demand for high-quality, dependable pharmaceutical ingredients, led by the quickening pace of progress in small molecule Active Pharmaceutical Ingredients (APIs). Being the foundation of hundreds of medicines, small molecule APIs are a huge part of the pharmaceutical […]
Smart Drug Delivery Systems Redefine Healthcare Innovation
Smart Drug Delivery Systems: Emerging Market Trends Driven by technical developments and a growing need for customised treatment alternatives, the global healthcare industry is changing quickly. Among the creative developments, smart drug delivery systems (SDDS) have emerged as a major one. Transforming the delivery of medicines, particularly for chronic and complex diseases like neurological […]
Interview with Laurent Van Lerberghe and David Buller, Managing Partners, KELES
In this exclusive interview, World Pharma Today sits down with Laurent Van Lerberghe and David Buller, the Managing Partners of KELES, deeply engaged in ethical AI investments, particularly within the healthcare and pharmaceutical sectors. The conversation explores their insights into the role of ethical AI in business, challenges in transparency and accountability, compliance with evolving […]
Debiopharm and Oncodesign Services Launch Strategic Collaboration to Propel Radiopharmaceuticals in Preclinical Research
Martigny, Switzerland. Dijon, France – Debiopharm Research & Manufacturing S.A. (Debiopharm, www.debiopharm.com), a Swiss-based global biopharmaceutical company aiming to cure cancer and infectious diseases, and Oncodesign Services (www.oncodesign-services.com), a leading CRO specialized in drug discovery and preclinical services, announce the execution of a license agreement for the use of the AbYlink™ technology for preclinical services. AbYlink™ […]
Сумма инвестиций в фармотрасль достигнет $40 млн до конца 2030 года
Около 5 млн долларов инвестировала иностранная компания AstraZeneca Kazakhstan в развитие нашей фармацевтической индустрии. Об этом на встрече с Премьер-министром сообщила директор компании, передает «24KZ». До 2030 года сумма инвестиций достигнет 40 млн долларов. А первую партию товара выпустят через месяц. Как отмечают инвесторы, поддержка со стороны государства вызывает заинтересованность в открытии производств в Казахстане. […]
